Recombinant Anti-FGF2 x Anti-VEGF Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-FGF2 antibody variable domain is fused to the C terminal of an IgG of anti-VEGF antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Hepatocellular cancer (HCC); Breast cancer; Colon cancer; Lung cancer; Glioma cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-FGF2 x Human Anti-VEGF Bispecific Antibody (IgG-Fv) (BSGV-H326). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS